RPG Life Sciences Limited (NSE:RPGLIFE)
India · Delayed Price · Currency is INR 2,861.10
+204.30 (7.69%)
Jul 10, 2026, 3:29 PM IST
RPG Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1,505 | 287 | 197.2 | 248.2 | 569.4 |
Short-Term Investments | 400.1 | 1,100 | 160 | 315.5 | 128.6 |
Trading Asset Securities | 839 | 1,259 | 901.5 | 584.3 | - |
Cash & Short-Term Investments | 2,744 | 2,646 | 1,259 | 1,148 | 698 |
Cash Growth | 3.69% | 110.22% | 9.64% | 64.47% | 72.94% |
Accounts Receivable | 1,167 | 867.6 | 491.3 | 374.3 | 329.9 |
Other Receivables | 106 | 76.6 | 18.1 | 14.4 | 42.6 |
Receivables | 1,273 | 944.2 | 509.4 | 388.9 | 372.7 |
Inventory | 1,238 | 929.8 | 1,010 | 950.5 | 829.9 |
Prepaid Expenses | 49.8 | 24.5 | 25.3 | 30.7 | - |
Other Current Assets | 290.1 | 108 | 177.5 | 122.4 | 168.5 |
Total Current Assets | 5,595 | 4,653 | 2,981 | 2,641 | 2,069 |
Property, Plant & Equipment | 2,117 | 1,651 | 1,818 | 1,163 | 1,001 |
Long-Term Investments | 10.1 | 10.1 | 10.1 | - | - |
Other Intangible Assets | 81.1 | 227.6 | 280.3 | 334 | 346.8 |
Long-Term Deferred Tax Assets | - | 10 | 5.8 | - | - |
Other Long-Term Assets | 127 | 24.9 | 31.6 | 54.2 | 27.7 |
Total Assets | 7,932 | 6,578 | 5,129 | 4,194 | 3,446 |
Accounts Payable | 972.5 | 793.9 | 710.2 | 646.9 | 455 |
Accrued Expenses | 301.3 | 197.1 | 306.2 | 217.8 | 145.5 |
Short-Term Debt | - | - | - | - | 2.1 |
Current Portion of Long-Term Debt | 66.7 | - | - | 0.1 | 0.7 |
Current Portion of Leases | - | - | - | - | 3.6 |
Current Income Taxes Payable | 12.4 | - | 27.2 | - | 3.8 |
Other Current Liabilities | 252.8 | 207.3 | 266 | 163 | 190.4 |
Total Current Liabilities | 1,606 | 1,198 | 1,310 | 1,028 | 801.1 |
Long-Term Debt | 133.3 | - | - | - | 0.1 |
Long-Term Leases | - | - | - | - | 2.9 |
Long-Term Deferred Tax Liabilities | 30.6 | - | - | 19.7 | 22.6 |
Other Long-Term Liabilities | 108.5 | 74.5 | 70.6 | 70 | 61.7 |
Total Liabilities | 1,878 | 1,273 | 1,380 | 1,118 | 888.4 |
Common Stock | 132.3 | 132.3 | 132.3 | 132.3 | 132.3 |
Additional Paid-In Capital | 344.4 | 344.6 | 344.6 | 344.6 | 344.6 |
Retained Earnings | 5,576 | 4,828 | 3,271 | 2,599 | 2,080 |
Comprehensive Income & Other | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Shareholders' Equity | 6,054 | 5,305 | 3,749 | 3,076 | 2,558 |
Total Liabilities & Equity | 7,932 | 6,578 | 5,129 | 4,194 | 3,446 |
Total Debt | 200 | - | - | 0.1 | 9.4 |
Net Cash (Debt) | 2,544 | 2,646 | 1,259 | 1,148 | 688.6 |
Net Cash Growth | -3.87% | 110.22% | 9.65% | 66.70% | 79.60% |
Net Cash Per Share | 153.80 | 159.99 | 76.10 | 69.41 | 41.63 |
Filing Date Shares Outstanding | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 |
Total Common Shares Outstanding | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 |
Working Capital | 3,989 | 3,454 | 1,671 | 1,613 | 1,268 |
Book Value Per Share | 366.01 | 320.77 | 226.65 | 185.98 | 154.65 |
Tangible Book Value | 5,972 | 5,078 | 3,468 | 2,742 | 2,211 |
Tangible Book Value Per Share | 361.11 | 307.01 | 209.70 | 165.79 | 133.68 |
Land | 109.4 | 109.4 | 202 | 202 | 23.4 |
Buildings | 927.3 | 770.2 | 477 | 464.1 | 329.7 |
Machinery | 1,492 | 1,203 | 865.9 | 865.4 | 662.3 |
Construction In Progress | 200.2 | 39.5 | 847.8 | 150.3 | 254.5 |